Diagnostyka

Diagnostyka Current Liabilities

The Current Liabilities of Diagnostyka (DIA.WA) as of Oct 27, 2026 is 209.61 M PLN. In the previous year, Current Liabilities was 346.81 M PLN — a change of -39.56% (lower).

Current Liabilities

209.61 MPLN

YoY

-39.56%

Last updated:

Current Liabilities of Diagnostyka is 2025 209.61 M PLN. Current Liabilities of Diagnostyka was 2024 346.81 M PLN. It decreases by -39.56% lower compared to the previous year.

The Diagnostyka Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2021
99.96 M PLN
Jan 1, 2022
91.65 M PLN
Jan 1, 2023
288.47 M PLN
Jan 1, 2024
346.81 M PLN
Jan 1, 2025
209.61 M PLN
The Diagnostyka Current Liabilities history
YEARCurrent LiabilitiesYoY
209.61 MPLN-39.56%
346.81 MPLN+20.22%
288.47 MPLN+214.76%
91.65 MPLN-8.32%
99.96 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

Current Liabilities of Diagnostyka is 209.61 M PLN in 2025.

Current Liabilities of Diagnostyka changed from 346.81 M PLN to 209.61 M PLN, representing a -39.56% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Diagnostyka historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Diagnostyka

All Key Metrics — Diagnostyka